England - London • TMT (technology, media and telecoms)
5

Intellectual property: patents (contentious and non-contentious)

logo

Venner Shipley LLP

Mehr Information
Regularly appearing before the EPO and UKIPO, Venner Shipley LLP's (formerly AA Thornton) contentious offering counts notable inventors and SMEs across the life sciences, telecoms, and engineering sectors, to name a few, in its client base. The practice is jointly led by Geoff Hussey , who capitalises on his science background to handle patent disputes across the life sciences and pharmaceutical sectors, and Daniel Byrne , who has experience with AI, quantum computing, and renewable energy patent litigation.
Legal 500 redaktioneller Kommentar
Profil
vennershipley.co.uk

Auszeichnungen

Mandantenzufriedenheit

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘Deeply immerse themselves in the case and find well-thought-out solutions.’

  • ‘Quick responses, we get all updates on time, and the reminders well in advance so we can decide the course of action.’

  • ‘Quick responses, diligent and proactive employees and partners.’

  • 'A firm with highly developed expertise in all areas of intellectual property. The firm is also able to provide very practical solutions and adapt to its clients' needs.'

  • 'In terms of invoicing, they are also highly adaptable, always able to find a solution in line with the financial capabilities of the clients they assist.’

  • 'Highly qualified experts in their field of practice, but also extremely practical and friendly, which makes working with them a pleasure.'

  • 'Daniel Byrne is an incomparable lawyer. His advice is always of the highest quality, based on an exceptional knowledge of the law and very careful thought.’

  • ‘Very responsive. Clear and astute advice.'

Kernmandanten

  • Quantinuum
  • Zaun Limited
  • CellmAbs
  • SUN Pharma
  • Unichem
  • Robert Bosch GmbH
  • Oil States International Inc.
  • Cipla
  • Aristo Pharma GmbH
  • Novartis

Highlight-Mandate

  • Acting for Zaun Limited in defending a claim for design right infringement in a patented product.
  • Advised a number of generic pharmaceutical clients on the merits of bringing cases against certain patents to invalidate them and to clear the way to launch generic drugs in the UK.
  • Assisting a biotech spin-out company with valuable licence rights and intellectual property of its own to commercialise its technology and maximise the chances of therapeutic products being developed.

Anwält*innen

Praxisleitung

Geoff Hussey; Daniel Byrne

Weitere Kernanwält*innen

Alex Bone; Adrian Bennett; Craig Turner; Mike Jennings